• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsRadiopharm Theranostics
    Picture of Radiopharm Theranostics logo

    RAD — Radiopharm Theranostics News Story

    AU$0.020.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    • Market Cap
      AU$70.88m
    • Enterprise Value
      AU$34.53m
    • Revenue
      AU$3.63m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • RAD Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    RAD Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:53 AM

    Picture of Radiopharm Theranostics logoRadiopharm Theranostics
    15/12/2025 14:53
    NASDAQ TRADE HALT  RADX.O  VOLATILITY TRADING PAUSE AT 09:53 AM
    

    Recent news on Radiopharm Theranostics

    See all news
    • Brief: Radiopharm Theranostics Advances To Cohort 3 In 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial

      08/04/2026 13:14
    • Brief: Radiopharm Theranostics And Siemens Healthineers Sign Clinical Supply Agreement For Rad101 In The U.S.

      07/04/2026 12:28
    • Brief: Radiopharm Theranostics Says RAD And Siemens Sign Clinical Supply Agreement For Rad101

      07/04/2026 03:28
    • Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart

      24/02/2026 13:02
    • Brief: Radiopharm Theranostics Says Co Increases Ownership In Radiopharm Ventures To 87.5%

      12/01/2026 01:14

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.